Skip to main content

Stable Oral Availability of Atenolol Coadministered with Hydralazine

Comparison with Propranolol, Metoprolol and Other β-Adrenoceptor Antagonists


A study was made of the influence of hydralazine on the oral availability of atenolol, a low clearance hydrophilic β- adrenoceptor antagonist. Atenolol (100mg) was given orally alone or in combination with oral hydralazine (25 or 50mg) on separate occasions to 6 normal healthy volunteers. Blood samples were collected post- dose over 9 hours and urine samples for 24 hours. Assays for atenolol were performed using a specific high pressure liquid chromatography technique.

Peak concentrations of atenolol, time to peak and area under the plasma concentration- time curve (AUC) were not altered by coadministration of either dose of hydralazine. Similarly, there were no differences in the urinary recovery or renal clearance of atenolol.

These results are in agreement with findings on coadministration of hydralazine with other β- blockers (nadolol, acebutolol) with low hepatic clearance, but contrast with the findings of increased AUC and peak concentrations when hydralazine was coadministered with propranolol and metoprolol.

Combination therapy with β- blockers and vasodilators is widely used, exploiting pharmacodynamic synergism. If vasodilator- induced changes in splanchnic blood flow mediate alterations in oral availability, then all high clearance β- blockers may show this interaction, indicating potential therapeutic advantage for those β- blockers which show low hepatic clearance.

This is a preview of subscription content, access via your institution.


  • Benet, L.Z. and Sheiner, L.B.: Design and optimisation of dosage regimens: pharmacokinetic data; in Goodman and Gilman (Eds) The Pharmacological Basis of Therapeutics, pp. 1675–1737 (McMillan Publishing Co., New York 1980).

    Google Scholar 

  • Brown, H.C.; Carruthers, S.G.; Johnston, G.O.; Kelly, J.G.; McAinsh, J.; McDevitt, D.G. and Shanks, R.G.: Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clinical Pharmacology and Therapeutics 20: 524–534 (1976).

    PubMed  CAS  Google Scholar 

  • Cruickshank, J.M.: The clinical importance of cardioselectivity and lipophilicity in beta-blockers. American Heart Journal 100: 160–178 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Daniel, W.W.: Applied Nonparametric Statistics (Houghton Mifflin Company, Boston 1978).

    Google Scholar 

  • Fitzgerald, J.D.; Ruffin, R.; Smedstad, K.G.; Roberts, R. and McAinsh, J.: Studies on the pharmacokinetics and pharmacodynamics of atenolol in man. European Journal of Clinical Pharmacology 13: 81–89(1978).

    Article  PubMed  CAS  Google Scholar 

  • Heinzow, B.G.J. and McLean, A.J.: Apparent flow-dependent hepatic clearance of propranolol incompatible with the venous equilibrium model of sinusoidal extraction. American Society for Clinical Pharmacology and Therapeutics, Abstract C20 (March 1982).

  • Henry, J.A.; Ohasi, K.; West, C. and Britton, K.E.: Acute effects of hydralazine and indoramin on renal function in man. British Journal of Clinical Pharmacology 12: 755–775 (1981).

    Article  Google Scholar 

  • Jack, D.B.; Kendall, M.J.; Dean, S.; Laugher, S.J.; Zaman, R. and Tenneson, M.E.: The effects of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol and acebutolol. Biopharmaceutics and Drug Disposition 3: 47–54 (1982).

    Article  CAS  Google Scholar 

  • McLean, A.J.; McNamara, P.J.; du Souich, P.; Gibaldi, M. and Lalka, D.: Food, splanchnic blood flow and bioavailability of drugs subject to first-pass metabolism. Clinical Pharmacology and Therapeutics 24: 5–10 (1978).

    PubMed  CAS  Google Scholar 

  • McLean, A.J.; Skews, H.; Bobik, A. and Dudley, F.J.: Interaction between oral propranolol and hydralazine. Clinical Pharmacology and Therapeutics 27: 726–732 (1980).

    Article  PubMed  CAS  Google Scholar 

  • McLean, A.J.; Isbister, C.; Bobik, A. and Dudley, F.J.: Reduction of first-pass hepatic clearance of propranolol by food. Clinical Pharmacology and Therapeutics 30: 31–34 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Melander, A.: Influence of food on the bioavailability of drugs. Clinical Pharmacokinetics 3: 337–351 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Melander, A.; Danielson, K.; Schersten, B. and Wahlin, E.: Enhancement of the bioavailability of propranolol and metoprolol by food. Clinical Pharmacology and Therapeutics 22: 108–112 (1977).

    PubMed  CAS  Google Scholar 

  • Melander, A.; Stenberg, P.; Liedholm, H.; Schersten, B. and Wahlin-Boll, E.: Food-induced reduction in bioavailability of atenolol. European Journal of Clinical Pharmacology 16: 327–330 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Pang, K..S. and Rowland, M.: Hepatic clearance of drugs. I: Theoretical considerations of a ‘well stirred’ model and a ‘parallel-tube’ model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzyme activity on hepatic drug clearance. Journal of Pharmacokinetics and Biopharmaceutics 5: 625–653 (1977).

    CAS  Google Scholar 

  • Waal-Manning, H.J.: Hypertension: Which beta-blocker? Drugs 12: 412–441 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Walle, T.; Fagen, T.C.; Walle, U.K.; Oexmann, M.J.; Conradi, EC. and Gaffney, T.E.: Food induced increase in propranolol bioavailability. Relationship to protein and effects on metabolites. Clinical Pharmacology and Therapeutics 30: 790–795 (1981).

    CAS  Google Scholar 

  • Weddle, O.H.; Amick, E.N. and Mason, W.D.: Rapid determination of atenolol in human plasma and urine by high-pressure liquid chromatography. Journal of Pharmaceutical Sciences 67: 1033–1035 (1978).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and Permissions

About this article

Cite this article

McLean, A.J., Wilhelm, D. & Heinzow, B.G. Stable Oral Availability of Atenolol Coadministered with Hydralazine. Drugs 25 (Suppl 2), 131–135 (1983).

Download citation

  • Published:

  • Issue Date:

  • DOI:


  • Propranolol
  • Atenolol
  • Hydralazine
  • Nadolol
  • Splanchnic Blood Flow